A critical investigation has shown that activation of endogenous TP53 downregulates the MVA pathway in human SK-HEP-1 hepatocellular carcinoma cells, HCT116 colon cancer cells, and mouse embryonic fibroblasts (MEFs) [28]. This evidence concerns the gene TP53 and colonic neoplasm.